Background Information

Nordion is a global leader in supplying the world's medical isotopes used to capture medical images. These images enable physicians to better diagnose and treat a multitude of diseases including cardiac and neurological conditions, in addition to several types of cancers.  Even today, nuclear medicine is one of the most powerful analytical tools available to physicians and patients because of its ability to provide dynamic views of organ structure and function.

Nordion's highest priority has always been the safe, effective and reliable supply of medical isotopes to meet the needs of the medical community and the patients we serve. In the early 1990s Nordion recognized the serious nature of the aging global reactor infrastructure and contracted to have two nuclear reactors and a processing facility brought into service. This project became known as the MAPLE project and was intended to secure a long-term supply of medical isotopes.

The solution to the medical isotope crisis is in Canada. Canada supplies a significant amount of the world's medical isotopes. Nordion and many Canadian and international experts still believe the completion of the MAPLE project is the best solution to provide a secure long-term supply of medical isotopes.

Background Documents


Videos
The May 2009 NRU shutdown was unexpected, but Nordion used this period productively. Watch the video to see what Nordion did to prepare for the 2010 return to service. As leaders in the nuclear medicine industry, we take the responsibility to the markets we serve very seriously. Watch this video to understand the Logistics of Lifesaving: Two Days in the Life of Mo-99.
footer